{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-15/paragraph-2",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-15/paragraph-2.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "schedule/15/paragraph/2",
  "kind": "paragraph",
  "number": "2",
  "heading": null,
  "text": "A medicinal product that contains ibuprofen and that is in the form specified in column 1 of the following table must be presented for sale in a separate and individual package containing not more than the amount of the product specified in the corresponding entry in column 2—\nForm of product\nMaximum amount\nTablets\n16 tablets\nCapsules\n16 capsules\nPowder or granules\n12 sachets\nLiquid preparations of ibuprofen\nIndividual unit doses of not more than 5 millilitres each, to a maximum of 20 unit doses",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/schedule/15/paragraph/2",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}